Overview

A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects

Status:
Recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single intravenous administration of SHR-1707 in healthy young adult and elderly subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Hengrui Pharmaceutical Co., Ltd.